November 13, 2017 / 9:55 AM / a month ago

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

Nov 13(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd

* Says co’s Shanghai-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration recently, for a kind of bulk drug, with valid period until Sept. 7, 2022

Source text in Chinese: goo.gl/fMCbsg

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below